NTRK Gene Fusion - Positive Advanced or Recurrent Solid Tumors, a Rare Cancer Caused by Specific Changes in the Genes

Clinical trial NCT04945330 · RECRUITING

Trial details

NCT number: NCT04945330
Sponsor: Bayer
Status: RECRUITING
Study type: OBSERVATIONAL

Advanced or Recurrent Solid Tumor Harboring an NTRK Gene Fusion

Start date: 2021-11-05
Primary completion: 2029-06-30
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.